miR-140-5p Ameliorates Atrial Fibrillation in Cardiomyocytes by Targeting the Water Channel Protein Aquaporin 4

Bokyeong Park1,2, Young Hoon Son3, Sung Jin Park3

  • 1Department of Molecular Medicine, Ewha Womans University School of Medicine, Seoul, Korea.

PubMed
Abstract

Insights

MicroRNA-140-5p (miR-140-5p) suppresses aquaporin 4 (AQP4) expression, reducing inflammation and calcium-handling protein phosphorylation. This finding suggests miR-140-5p may alleviate atrial fibrillation (AF) by targeting AQP4.

Area of Science:

  • Molecular Biology
  • Cardiovascular Research
  • Gene Regulation

Background:

  • MicroRNAs (miRNAs) regulate gene expression and are implicated in atrial fibrillation (AF) pathogenesis.
  • Aquaporin 4 (AQP4) is a water channel protein potentially involved in AF.
  • This study explores the role of specific miRNAs in regulating AQP4 and mitigating AF.

Purpose of the Study:

  • To investigate the role of miR-140-5p in regulating AQP4 expression.
  • To determine if miR-140-5p can alleviate inflammation and calcium-handling protein abnormalities in a cellular model of AF.
  • To assess the potential of miR-140-5p as a therapeutic target for AF.

Main Methods:

  • HL-1 cells were transfected with miR-140-5p or a control miRNA.
  • Cells were subjected to tachypacing (TP) to induce an AF-like state.
  • Protein and mRNA expression of AQP4, inflammation markers, and calcium-handling proteins were analyzed using Western blotting and real-time PCR.

Main Results:

  • Tachypacing increased miR-140-3p, AQP4, and inflammation markers (TLR4, NLRP3, ERK, AKT, IL-1β).
  • miR-140-5p treatment mitigated the TP-induced increases in AQP4 and inflammation markers.
  • miR-140-5p also reduced the expression of calcium-handling proteins (CaMKII, phospholamban, RyR2) in TP-induced AF cells.

Conclusions:

  • miR-140-5p suppresses AQP4 expression in a cellular model of AF.
  • This suppression alleviates inflammation and abnormal phosphorylation of calcium-handling proteins.
  • miR-140-5p demonstrates potential as a therapeutic agent for reducing AF risk.

Related Concept Videos